RxDoctor Payments Data

Benjamin Saviet, DPM

Foot & Ankle Surgery · Worcester, MANPI 1134533813

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (56.3%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Kairos Surgical Inc at 45.9% of the total. Reporting peaked in 2021 at $3,129 and has fallen 92.8% since, to $224 in 2025.

$9,402in general payments, 2019–2025

Across 82 payments — averaging $114.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kairos Surgical Inc$4K
  • Arthrex$2K
  • Paragon 28, Inc.$763
  • Stryker$550
  • Zimmer Biomet$501
  • Fusion Orthopedics USA, LLC$251
  • plus $1K from 16 others

What the payments were for

  • Speaking & faculty fees$7508%
  • Travel & lodging$7148%
  • Food & beverage$2,54927%
  • Education$5,29456%
  • Gifts$941%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,402 in reported general payments places this provider in the 85th percentile of 122 foot & ankle surgery providers in Massachusetts.

See all foot & ankle surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$175,238
Medicare patients
389
Services billed
17,238

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
QutenzaCapsaicin/Skin Cleanser20$70,965
EliquisApixaban15$11,825
Celecoxib92$1,328
Ketoconazole15$588
Cephalexin17$138
Hydroxyzine Pamoate18$75
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen22$70

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Worcester

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →